Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Identifying and enumerating tumor-specific CD8 T cells are important for assessing cancer prognosis and therapy efficacy. Here the authors show that CD39 and CD103 mark a subset of tumor-infiltrating CD8 T cells that are tumor-reactive and exhibit characteristics of exhausted or tissue-resident memo...
Main Authors: | Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F. de Miranda, Cheri P. Goodall, Tiffany C. Blair, Bernard A. Fox, Jason E. McDermott, Shu-Ching Chang, Gary Grunkemeier, Rom Leidner, Richard Bryan Bell, Andrew D. Weinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-05072-0 |
Similar Items
-
172 Increasing activation of human tumor-reactive T cells (CD39+CD103+CD8+) by gene silencing of PD1 with self-delivering RNAi INTASYL(TM)
by: Andrew Weinberg, et al.
Published: (2020-11-01) -
Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer
by: Hagma H. Workel, et al.
Published: (2020-05-01) -
High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
by: Elisabet Aliagas, et al.
Published: (2014-01-01) -
CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
by: Zhu W, et al.
Published: (2021-03-01) -
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
by: Fenne L. Komdeur, et al.
Published: (2017-09-01)